PT Kimia Farma Persero Tbk (ISX:KAEF) Cyclically Adjusted FCF per Share: Rp (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:KAEF PT Kimia Farma Persero Tbk ISX:KAEF
53 GF Score
Price Rp440.00
GF Value Rp574.38
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Kimia Farma Persero Tbk Cyclically Adjusted FCF per Share?

PT Kimia Farma Persero Tbk ISX:KAEF -1.34% 53 Cyclically Adjusted FCF per Share is Rp as of Jun. 2026. GuruFocus rates ISX:KAEF with a GF Score™ of 53/100 and a GF Value™ of Rp574.38 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

PT Kimia Farma Persero Tbk's adjusted free cash flow per share for the three months ended in Jun. 2026 was Rp-33.230. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is Rp for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -10.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -16.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of PT Kimia Farma Persero Tbk was -10.70% per year. The lowest was -25.00% per year. And the median was -17.60% per year.

As of today (2026-09-22), PT Kimia Farma Persero Tbk's current stock price is Rp440.00. PT Kimia Farma Persero Tbk's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was Rp. PT Kimia Farma Persero Tbk's Cyclically Adjusted Price-to-FCF of today is .


PT Kimia Farma Persero Tbk  (ISX:KAEF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


PT Kimia Farma Persero Tbk Cyclically Adjusted FCF per Share Related Terms


PT Kimia Farma Persero Tbk Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for PT Kimia Farma Persero Tbk's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kimia Farma Persero Tbk Cyclically Adjusted FCF per Share Chart

PT Kimia Farma Persero Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PT Kimia Farma Persero Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ISX:KAEF vs MCK, COR, CAH: Cyclically Adjusted FCF per Share Comparison

For the Medical Distribution subindustry, PT Kimia Farma Persero Tbk's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kimia Farma Persero Tbk Cyclically Adjusted Price-to-FCF vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Persero Tbk's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where PT Kimia Farma Persero Tbk's Cyclically Adjusted Price-to-FCF falls into.


ISX:KAEF
53GF Score
PT Kimia Farma Persero Tbk ISX:KAEF
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Kimia Farma Persero Tbk Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Kimia Farma Persero Tbk's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-33.23/137.6954*137.6954
=-33.230

Current CPI (Jun. 2026) = 137.6954.

PT Kimia Farma Persero Tbk Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -25.214 104.142 -33.338
201612 69.286 105.222 90.669
201703 -76.207 106.476 -98.551
201706 -45.903 107.722 -58.676
201709 -53.978 108.020 -68.807
201712 46.598 109.017 58.856
201803 -98.547 110.097 -123.251
201806 -85.617 111.085 -106.127
201809 -166.369 111.135 -206.131
201812 167.571 112.430 205.228
201903 -297.415 112.829 -362.964
201906 73.340 114.730 88.020
201909 -131.645 114.905 -157.756
201912 -115.031 115.486 -137.153
202003 -55.514 116.252 -65.754
202006 -35.107 116.630 -41.448
202009 -8.328 116.397 -9.852
202012 185.730 117.318 217.990
202103 -107.470 117.840 -125.578
202106 -43.622 118.184 -50.824
202109 -77.196 118.262 -89.881
202112 72.364 119.516 83.371
202203 -49.351 120.948 -56.184
202206 -114.432 123.322 -127.769
202209 8.835 125.298 9.709
202212 67.817 126.098 74.054
202303 -129.836 126.953 -140.823
202306 -75.359 127.663 -81.281
202309 -66.255 128.151 -71.189
202312 72.215 129.395 76.848
202403 -6.418 130.607 -6.766
202406 -21.875 130.792 -23.030
202409 -25.962 130.361 -27.423
202412 48.132 131.432 50.426
202503 -33.603 131.948 -35.067
202506 1.444 133.241 1.492
202509 31.710 133.819 32.629
202512 19.216 135.271 19.560
202603 12.798 136.539 12.906
202606 -33.230 137.695 -33.230

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of Rp mean?
PT Kimia Farma Persero Tbk (ISX:KAEF) has a Cyclically Adjusted FCF per Share of Rp as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on PT Kimia Farma Persero Tbk and its competitors.
Is PT Kimia Farma Persero Tbk's Cyclically Adjusted FCF per Share too high?
PT Kimia Farma Persero Tbk's current Cyclically Adjusted FCF per Share is Rp. Overall, PT Kimia Farma Persero Tbk has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Persero Tbk's Cyclically Adjusted FCF per Share compare to MCK and COR?
PT Kimia Farma Persero Tbk's Cyclically Adjusted FCF per Share of Rp can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Distribution company?
A good Cyclically Adjusted FCF per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on PT Kimia Farma Persero Tbk and its competitors. PT Kimia Farma Persero Tbk's current Cyclically Adjusted FCF per Share is Rp. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Persero Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp574.38, compared to a current price of Rp440.00 — trading 23.4% below its estimated fair value. The current Cyclically Adjusted FCF per Share is Rp. PT Kimia Farma Persero Tbk's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For PT Kimia Farma Persero Tbk (ISX:KAEF), the current Cyclically Adjusted FCF per Share is Rp as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kimia Farma Persero Tbk (ISX:KAEF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk stock appears to be undervalued. The current stock price of Rp440.00 is trading 23.4% below its estimated GF Value™ of Rp574.38. GuruFocus considers PT Kimia Farma Persero Tbk to be Modestly Undervalued.

Key valuation signals for ISX:KAEF:

  • Cyclically Adjusted FCF per Share: Rp
  • GF Value™: Rp574.38 vs. price of Rp440.00 (23.4% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Kimia Farma Persero Tbk Business Description

Address Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
53GF Score

Get the complete analysis for ISX:KAEF

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp440.00
Price
Rp574.38
GF Value